Found: 36
Select item for more details and to access through your institution.
The Controlling Nutritional Status Score Is a Significant Independent Predictor of Poor Prognosis in Patients With Malignant Pleural Mesothelioma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Clinical course and prognosis of patients with lung cancer who develop anticancer therapy-related pneumonitis.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2021, v. 147, n. 6, p. 1857, doi. 10.1007/s00432-020-03478-2
- By:
- Publication type:
- Article
Histological conversion from adenocarcinoma to small cell carcinoma of the lung after treatment with an immune checkpoint inhibitor: a case report.
- Published in:
- Oxford Medical Case Reports, 2020, v. 20, n. 4/5, p. 1, doi. 10.1093/omcr/omaa026
- By:
- Publication type:
- Article
Identification of the Best Prognostic Marker Among Immunonutritional Parameters Using Serum C-Reactive Protein and Albumin in Non-Small Cell Lung Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 6, p. 3046, doi. 10.1245/s10434-020-09230-x
- By:
- Publication type:
- Article
Prognostic Impact of Smoking Period in Patients with Surgically Resected Non-small Cell Lung Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 2, p. 685, doi. 10.1245/s10434-020-08851-6
- By:
- Publication type:
- Article
Necitumumab plus gemcitabine and cisplatin in previously treated lung squamous cell carcinoma.
- Published in:
- Investigational New Drugs, 2023, v. 41, n. 1, p. 168, doi. 10.1007/s10637-022-01312-9
- By:
- Publication type:
- Article
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study.
- Published in:
- International Journal of Clinical Oncology, 2024, v. 29, n. 8, p. 1142, doi. 10.1007/s10147-024-02543-x
- By:
- Publication type:
- Article
Gemcitabine and vinorelbine as second-line or beyond treatment in patients with malignant pleural mesothelioma pretreated with platinum plus pemetrexed chemotherapy.
- Published in:
- International Journal of Clinical Oncology, 2014, v. 19, n. 4, p. 601, doi. 10.1007/s10147-013-0619-5
- By:
- Publication type:
- Article
Acute Generalized Exanthematous Pustulosis Caused by the Combination of Pembrolizumab Plus Chemotherapy in a Patient With Squamous-Cell Carcinoma.
- Published in:
- 2020
- By:
- Publication type:
- Case Study
Concurrent Chemoradiotherapy for Patients With Postoperative Recurrence of Surgically Resected Non--Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2015, v. 16, n. 1, p. 51, doi. 10.1016/j.cllc.2014.06.001
- By:
- Publication type:
- Article
Concurrent chemoradiotherapy for patients with postoperative recurrence of surgically resected non-small-cell lung cancer.
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Impact of the epidermal growth factor receptor mutation status on the post-recurrence survival of patients with surgically resected non-small-cell lung cancer†.
- Published in:
- European Journal of Cardio-Thoracic Surgery, 2015, v. 47, n. 3, p. 550, doi. 10.1093/ejcts/ezu227
- By:
- Publication type:
- Article
Prognostic impact of primary cancer adjoining emphysematous bullae in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 6, p. 1745, doi. 10.1007/s00262-020-02783-6
- By:
- Publication type:
- Article
Prospective observational study of nutritional/immunologic indices as predictive biomarkers for the response to anti-PD-1 drugs in non-small cell lung cancer (ICI-PREDICT study).
- Published in:
- PLoS ONE, 2021, v. 16, n. 10, p. 1, doi. 10.1371/journal.pone.0258616
- By:
- Publication type:
- Article
Pneumonectomy after induction chemoradiotherapy for locally advanced non-small cell lung cancer: should curative intent pulmonary resection be avoided?
- Published in:
- Surgery Today, 2019, v. 49, n. 3, p. 197, doi. 10.1007/s00595-018-1751-7
- By:
- Publication type:
- Article
A typical carcinoid tumor of the lung presenting with pure persistent ground-glass opacity on high-resolution computed tomography: a case report.
- Published in:
- Surgical Case Reports, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s40792-017-0382-3
- By:
- Publication type:
- Article
Uncommon features of surgically resected ALK-positive cavitary lung adenocarcinoma: a case report.
- Published in:
- Surgical Case Reports, 2017, v. 3, n. 1, p. 1, doi. 10.1186/s40792-017-0322-2
- By:
- Publication type:
- Article
Phase 1 study of DS‐1205c combined with gefitinib for EGFR mutation‐positive non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 6, p. 7090, doi. 10.1002/cam4.5508
- By:
- Publication type:
- Article
Targeted Therapy for RET Fusion Lung Cancer: Breakthrough and Unresolved Issue.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.704084
- By:
- Publication type:
- Article
c-Kit mutation-positive advanced thymic carcinoma successfully treated as a mediastinal gastrointestinal stromal tumor: A case report.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Amrubicin as Second-line and Beyond Treatment for Platinum-refractory Advanced Thymic Carcinoma.
- Published in:
- Japanese Journal of Clinical Oncology, 2013, v. 43, n. 10, p. 1018, doi. 10.1093/jjco/hyt106
- By:
- Publication type:
- Article
Successful treatment of locally advanced lung cancer using late concurrent chemoradiation therapy administered after immune checkpoint inhibitor plus platinum chemotherapy.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 23, p. 3286, doi. 10.1111/1759-7714.14200
- By:
- Publication type:
- Article
Sarcoid-like reaction of the extrathoracic lymph node in a patient with lung adenocarcinoma treated with pembrolizumab.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 14, p. 2122, doi. 10.1111/1759-7714.14011
- By:
- Publication type:
- Article
Dramatic intracranial response to tepotinib in a patient with lung adenocarcinoma harboring MET exon 14 skipping mutation.
- Published in:
- Thoracic Cancer, 2021, v. 12, n. 6, p. 978, doi. 10.1111/1759-7714.13871
- By:
- Publication type:
- Article
Cohesion between pulmonary artery and bronchus after immune checkpoint inhibitor therapy in a lung cancer patient.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 12, p. 3605, doi. 10.1111/1759-7714.13697
- By:
- Publication type:
- Article
Brain cavernous hemangioma mimicking radiation‐induced necrosis in a patient with non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 7, p. 2056, doi. 10.1111/1759-7714.13494
- By:
- Publication type:
- Article
Short progression‐free survival of ALK inhibitors sensitive to secondary mutations in ALK‐positive NSCLC patients.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 9, p. 1779, doi. 10.1111/1759-7714.13143
- By:
- Publication type:
- Article
Predictive and prognostic impact of primary tumor‐bearing lobe in nonsmall cell lung cancer patients treated with anti‐PD‐1 therapy.
- Published in:
- International Journal of Cancer, 2020, v. 147, n. 8, p. 2327, doi. 10.1002/ijc.33030
- By:
- Publication type:
- Article
Management of Peripheral Edema in Patients with MET Exon 14-Mutated Non-small Cell Lung Cancer Treated with Small Molecule MET Inhibitors.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab‐Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 475, doi. 10.1634/theoncologist.2019-0746
- By:
- Publication type:
- Article
Evaluation of erlotinib for the treatment of patients with non-small cell lung cancer with epidermal growth factor receptor wild type.
- Published in:
- Oncology Letters, 2017, v. 14, n. 1, p. 306, doi. 10.3892/ol.2017.6118
- By:
- Publication type:
- Article
Case report: Success of tepotinib therapy in overcoming resistance to osimertinib in a patient with EGFR-mutant lung adenocarcinoma with a potential acquired MET exon 14 skipping mutation.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.965741
- By:
- Publication type:
- Article
A randomized phase 3 study of maintenance therapy with S-1 plus best supportive care versus best supportive care after induction therapy with carboplatin plus S-1 for advanced or relapsed squamous cell carcinoma of the lung (WJOG7512L).
- Published in:
- 2020
- By:
- Publication type:
- journal article
Brigatinib in Japanese patients with ALK‐positive non‐small‐cell lung cancer: Final results of the phase 2 J‐ALTA trial.
- Published in:
- Cancer Science, 2023, v. 114, n. 9, p. 3698, doi. 10.1111/cas.15888
- By:
- Publication type:
- Article
Anti–PD-1 Monotherapy for Advanced NSCLC Patients with Older Age or Those with Poor Performance Status.
- Published in:
- OncoTargets & Therapy, 2021, v. 14, p. 1961, doi. 10.2147/OTT.S301500
- By:
- Publication type:
- Article